Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02632552 · ClinicalTrials.gov registry record · NA
A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD
A NA study of COPD and CHF, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 5
- Study locations
NCT02632552: Completed NA study of COPD and CHF, sponsored by VA Office of Research and Development.
NCT02632552 is a NA study of COPD and CHF that has completed, run by VA Office of Research and Development. The registered enrollment target is 140 participants, below the 2,417-participant average among 85 other COPD trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02632552, a NA study of COPD and CHF, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 5
- Study locations
Study Summary
Transition from hospital to home places patients in jeopardy of adverse events and increases their risk for rehospitalization. CHF is the most prevalent chronic condition among U.S. adults and COPD is the third leading cause of death in the U.S. Both CHF and COPD represent significant burdens for the VHA healthcare system. Care transitions can be supported through multi-component interventions, but are costly to implement. Virtual nurses provide an effective medium for explaining health concepts to patients, and previous work indicates patients find virtual nurses acceptable. The investigators will implement and evaluate a virtual nurse intervention to provide automated, tailored, and timely support to Veterans transitioning from hospital to home. As effective care transition interventions incorporate both inpatient and outpatient components, the virtual nurse will first engage with patient onscreen during their inpatient stay and then via text message post-discharge. This project has the potential to improve the care transition experience for patients, caregivers and healthcare providers.
Primary Outcome
Comparing Total Number of Combined Emergency and Urgent Care Utilization for Veterans with CHF and/or COPD between Intervention and Control across time. This measure is defined as the total number of VA emergency department visits and VA urgent care visits for each participant during the study period.
Interventions
- BEHAVIORAL Technology-assisted care transition intervention
- BEHAVIORAL Active attention control
Study Locations (5)
Massachusetts
- VA Bedford HealthCare System, Bedford, MA - Bedford
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Illinois
- Edward Hines Jr. VA Hospital, Hines, IL - Hines
Iowa
- Iowa City VA Health Care System, Iowa City, IA - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
What the finished NCT02632552 record still lists
NCT02632552 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 2,417-participant average among 85 other COPD trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with COPD appearing as the primary indexed condition, and to 2 interventions - of which Technology-assisted care transition intervention is the first listed.
NCT02632552 lists 5 locations in 4 states (Massachusetts, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT02632552 about?
NCT02632552 is a clinical study titled "A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD". Transition from hospital to home places patients in jeopardy of adverse events and increases their risk for rehospitalization. CHF is the most prevalent chronic condition among U.S. adults and COPD is the third leading cause of death in the U.S. Both CHF and COPD represent significant burdens for th...
What is the current status of trial NCT02632552?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2018-05-01. Estimated completion is 2021-08-31.
What conditions does trial NCT02632552 study?
This clinical trial studies the following conditions: COPD, CHF.
What interventions are being tested in trial NCT02632552?
The interventions under investigation include: Technology-assisted care transition intervention (BEHAVIORAL), Active attention control (BEHAVIORAL).
Who is sponsoring clinical trial NCT02632552?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02632552 being conducted?
This trial has 5 study locations across California, Illinois, Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02632552's enrollment target sits among peer trials
140 34th of 85 higher than 51 of 85 other COPD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
The Reducing REVISITS Study: A Cluster RCT
RECRUITING · NA
-
The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain
RECRUITING · NA
-
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI